Systemic blood pressure response to the inhibition of two hyperpolarizing pathways: A comparison to NO-synthase inhibition

Physiological Research

Volumn 55, Issue 6, 2006, Pages 603-610

  Gerova M ^a,b   Kittova M ^a  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Acetylcholine; Bradykinin; Hyperpolarizing factors; Hypertension; Nitric oxide; Systemic blood pressure

Indexed keywords

4 AMINOPYRIDINE; ACETYLCHOLINE; ARACHIDONIC ACID; BRADYKININ; CYTOCHROME P450; MICONAZOLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; HYPERPOLARIZATION; HYPOTENSION; MALE; NONHUMAN; RAT; SYSTEMIC CIRCULATION; VASCULAR SMOOTH MUSCLE;

4-AMINOPYRIDINE; ACETYLCHOLINE; ANIMALS; ARACHIDONIC ACID; BIOLOGICAL FACTORS; BLOOD PRESSURE; BRADYKININ; CAROTID ARTERIES; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MICONAZOLE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 33845890782     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. AHLUWALIA A, HOBBS AJ: Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends Pharmacol Sci 26: 162-167, 2005.
2. BAKKER EN, SIPKEMA P: Components of acetylcholine-induced dilation in isolated rat arterioles. Am J Physiol 273: H1848-H1853, 1997.
3. BAUERSACHS J, POPP R, HECKER M, SAUER E, FLEMING I, BUSSE R: Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94: 3341-3347, 1996.
4. BENY JL, VON DER WEID PY: Hydrogen peroxide: an endogenous smooth muscle cell hyperpolarizing factor. Biochem Biophys Res Commun 176: 378-384, 1991.
5. BENY JL, PACCICA C: Bidirectional electrical communication between smooth muscle and endothelial cells in the pig coronary artery. Am J Physiol 266: H1465-H1472, 1994.
6. + channel inhibitor 4-aminopyridine. Eur J Pharmacol 452: 325-337, 2002.
7. BOLOTINA VM, NAJIBI S, PALACINO JJ, PAGANO PJ COHEN RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
8. BOLTON TP, CLAPP LH: Endothelial-dependent relaxant action of carbachol and substance P in arterial smooth muscle. Br J Pharmacol 87: 713-723, 1986.
9. BRATZ IN, FALCON R, PARTRIDGE LD, KANAGY NL: Vascular smooth muscle cell membrane depolarization after NOS inhibition hypertension. Am J Physiol 282: H1648-H1655, 2002.
10. ω-nitro-L-arginine. Am J Physiol 289: H1277-H1283, 2005.
11. BUCHWALOW IB, PODZUWEIT T, SAMOILOVA VE, WELLNER M, HALLER H, GROTE S, ALETH S, BOECKER W, SCHMITZ W, NEUMANN J: An in situ evidence for autocrine function of NO in the vasculature. Nitric Oxide 10: 203-212, 2004.
12. BUSSE R, EDWARDS G, FÉLÉTOU M, FLEMING I, VANHOUTTE PM, WESTON AH: EDHF: bringing the concepts together. Trends Pharmacol Sci 23: 374-380, 2002.
13. CAMPBELL WB, GEMBREMEDHIN D, PRATT PF, HARDER DR: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
14. CHAYTOR AT, MARTIN PEM, EDWARDS DH, GRIFFITH TM: Gap junctional communication underpins EDHF-type relaxations evoked by acetylcholine in the rat hepatic artery. Am J Physiol 280: H2441-H2450, 2001.
15. COHEN RA, PLANE F, NAJIBI S, HUK I, MALINSKI T, GARLAND CJ: Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci USA 94: 4193-4198, 1997.
16. + channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 37: 1315-1322, 2001.
17. EDWARDS G, GARDENER MJ, FELETOU M, BRADY G, VANHOUTTE PM, WESTON AH: K is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
18. FELETOU M, VANHOUTTE PM: Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93: 515-524, 1988.
19. FLEMING I: Cytochrome P450 enzymes in vascular homeostasis. Circ Res 89: 753-762, 2001.
20. FULTON D, MCGIFF JC, QUILLEY J: Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-dependent vasodilator effect of bradykinin in the rat heart. J Pharmacol Exp Ther 287: 497-503, 1998.
21. GEROVÁ M: Acetylcholine and brakykinin induce paradoxically amplified hypotensive response in hypertensive NO-deficient rats. Physiol Res 48: 249-257, 1999.
22. GEROVÁ M, MASANOVÁ C, PAVLÁSEK J: Inhibition of NO synthase in the posterior hypothalamus increases blood pressure in the rat. Physiol Res 44: 131-134, 1995.
23. GEROVÁ M, MESÁROŠ Š, KRISTEK F, KITTOVÁ M, MALINSKI T: NO concentration in the periendothelial area of the femoral artery of the dog measured in vivo. Physiol Res 47: 169-175, 1998.
24. GEROVÁ M, TÖRÖK J, PECHÁÒOVÁ O, MATUŠKOVÁ J: Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production. Acta Pharmacol Sin 25: 1640-1646, 2004.
25. HALCOX JPJ, NARAYANAN S, CRAMER-JOYCE L, MINCEMOYER R, QUYYUMI AA: Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol 280: H2470-H2477, 2001.
26. HARADA Y, IKEDA M, MURASATO Y, SUZUKA H, NANRI H, HAYASHIDA Y: Integrative effects of nitric oxide and endothelium-derived hyperpolarizing factor induced by acetylcholine and bradykinin in rat hindquarter perfusion. Nitric oxide 4: 354-362, 2000.
27. HARDER DR, GEBREMEDHIN D, NARAYANAN J, JEFCOAT C, FALC JR, CAMPBELL UB, ROMAN R: Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessel. Am J Physiol 266: H2098-H2107, 1994.
28. HECKER M, BARA AT, BAUERSACHS J, BUSSE R: Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol Lond 481: 407-414, 1994.
29. JACKSON WF: Ion channels and vascular tone. Hypertension 35: 173-178, 2000.
30. G-nitro-L- arginine in anaesthetized rats. Clin Exp Pharmacol Physiol 25: 510-516, 1998.
31. KRISTEK F, GEROVÁ M: Myoendothelial relations in the conduit coronary artery of the dog and rabbit. J Vasc Res 29: 29-32, 1992.
32. KRISTEK F, GEROVÁ M: Endothelial muscle cell contacts in the coronary artery of the dog during development. Acta Anat 158: 166-171, 1997.
33. MATOBA T, SHIMOKAWA H, NAKASHIMA M, HIRAKAWA Y, MUKAI Y, HIRANO K, KANDAIDE H, TAKESHITA A: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
34. MUGGE A, LOPEZ JAG, PIEGORS DJ, BREESE KR, HEISTAD DD: Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am J Physiol 260: H242-H247, 1991.
35. NAGAO T, ILLIANO S, VANHOUTTE PM: Heterogenous distribution of endothelium-dependent relaxation resistant to N-nitro-L-arginine in rats. Am J Physiol 263: H1090-H1094, 1992.
36. NATHAN C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
37. NISHIKAWA Y, STEPP DW, CHILIAN WM: In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol 277: H1252-H1259, 1999.
38. OLTMAN CHL, KANE NL, FUDGE JL, WEINTRAUB NL, DELLSPERGER KC: Endothelium-derived hyperpolarizing factor in coronary microcirculation: responses to arachidonic acid. Am J Physiol 281: H1553-H1560, 2001.
39. PETERSSON J, ZYGMUNT PM, HOGESTATT ED: Characterization of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br J Pharmacol 120: 1344-1350, 1997.
40. POMPOSIELLO SI, QUILLEY J, CARROLL MA, FALCK JR, MCGIFF JC: 5.6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR. Hypertension 42: 548-554, 2003.
41. SEGAL SS, BRETT SE, SESSA WC: Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol 277: H1167-H1177, 1999.
42. TOROK J: Histamine-induced relaxation in pulmonary artery of normotensive and hypertensive rats: relative contribution of prostanoids, nitric oxide and hyperpolarization. Physiol Res 49: 107-114, 2000.
43. WIDMANN MD, WEINTRAUT NL, FRUDGE JL, BROOKS LA, DELLSPERGER KC: Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. Am J Physiol 274: H282-H289, 1998.
44. YEN MH, LEE SH, HO ST: Effects of 4-aminopyridine on cat blood pressure in relation to the sympathetic nervous system. Eur J Pharmacol 113: 61-67, 1985.
45. ZANCHI A, AUBERT JF, BRUNNER HR, WAEBER B: Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro. Cardiovasc Res 30: 122-129, 1995.